Introduction {#s1}
============

Spontaneous progression of cell cycles represents one of the most extensively studied biological oscillations. Cytoplasmic extracts predominantly from *Xenopus* eggs ([@bib22]) have made major contributions to the initial discovery and characterization of the central cell-cycle regulators including the protein complex cyclin B1-Cdk1 ([@bib19]; [@bib21]; [@bib17]; [@bib18]) and the anaphase-promoting complex or cyclosome (APC/C) ([@bib30]). Cell-free extracts have also been used to investigate downstream mitotic events such as spindle assembly and chromosome segregation ([@bib7]). Moreover, detailed dissections of the regulatory circuits in these extracts have revealed architecture of interlinked positive and negative feedbacks ([@bib15]; [@bib20]; [@bib37]; [@bib1]; [@bib32]; [@bib12]; [@bib27]; [@bib26]; [@bib24]; [@bib31]) ([Figure 1A](#fig1){ref-type="fig"}). Such interlinked feedback loops are also found in many other biological oscillators ([@bib28]; [@bib10]; [@bib3]; [@bib16]) and have been shown computationally to play an important role in achieving the essential clock functions such as robustness and tunability ([@bib33]). These studies have stimulated major interests in quantitative characterization of clock functions, for which an experimental platform is still lacking.

![Reconstitution of an in vitro cell cycle clock and downstream mitotic events.\
(**A**) Schematic view of a cell cycle oscillator that consists of coupled positive and negative feedback loops. The central regulator, cyclin B-Cdk1 complex activates its own activator, phosphatase Cdc25, forming a positive feedback loop, and inhibits its own inhibitor, kinase Wee1, forming a double negative feedback loop. Additionally, cyclinB-Cdk1 activates the E3 ubiquitin ligase APC/C, which targets cyclin B for degradation and completes a core negative feedback loop. Active APC/C also promotes the degradation of another substrate securin. Once cyclinB1-Cdk1 complex is activated, the circuit drives a set of mitotic events including chromosome condensation and nuclear envelope breakdown (NEB). (**B**) Experimental procedures. Cycling *Xenopus* extracts are supplemented with various combinations of recombinant proteins, mRNAs, and de-membraned sperm DNAs, which are encapsulated in 2% Perfluoropolyether-poly (ethylene glycol) (PFPE-PEG) oil microemulsions. Scale bar is 100 µm. (**C**) Snapshots of a droplet were taken periodically both in fluorescence channels (top three rows) and bright-field (the last row). The cyclic progression of the cell cycle clock and its downstream mitotic processes are simultaneously tracked by multiple fluorescence reporters. The clock regulator APC/C activity is reported by its substrate securin-mCherry, chromosomal morphology changes by the Hoechst stains, and NEB by GFP-NLS. Nuclear envelopes (red arrows) are also detectable on bright field images, matching the localization of GFP-NLS indicated nuclei. Scale bar is 30 µm. (**D**) Multi-channel measurements for the droplet in [Figure 1C](#fig1){ref-type="fig"}. The nucleus area (green circle) is calculated from the area of the nuclear envelope indicated by GFP-NLS, noting that the areas of the green circles are also scaled with the real areas calculated for the nuclei. DNA area curve (blue line) shows the chromosome area identified by Hoechst 33342 dye. Chromosome condensation happens almost at the same time as the nuclear envelope breaks down (black dashed line). The red dashed line represents the intensity of securin-mCherry over time, suggesting that degradation of the APC/C substrate lags behind NEB consistently at each cycle.](elife-33549-fig1){#fig1}

Compared to in vivo systems, circuits reconstituted in cell-free extracts contain well-defined recombinant molecules and are more amenable to systematic design, manipulation and quantitative biochemical measurements. However, one major limitation for most in vitro reconstitutions up to date is that oscillations are generated in well-mixed bulk solutions, which tend to produce quickly damped oscillations ([@bib27]; [@bib23]). Additionally, these bulk reactions lack the similarity to the actual cell dimensions and the ability of mimicking spatial organization achieved by functional compartmentalization in real cells. These limitations make it impossible to retrieve the cellular heterogeneity to investigate important and challenging questions, such as stochasticity and tunability of an oscillator.

To overcome these challenges, we developed an artificial cell cycle system by encapsulating reaction mixtures containing cycling *Xenopus* egg cytoplasm ([@bib22]) in cell-scale micro-emulsions. These droplet-based cells are stable for days and keep oscillating for dozens of cycles, offering large gains in high-throughput and long-term tracking of dynamical activities in individual droplets. In this system, we successfully reconstituted a series of mitotic events including chromosome condensation, nuclear envelope breakdown and destruction of anaphase substrates such as the proteins securin and cyclin B1. The oscillation profiles of the system such as period and number of cycles can be reliably regulated by the amount of cyclin B1 mRNAs or sizes of droplets. Additionally, we found that energy may be a critical factor for cell cycle behaviors.

Results and discussion {#s2}
======================

The oscillator reliably drives the periodic progression of multiple mitotic events {#s2-1}
----------------------------------------------------------------------------------

To create a cell-like in vitro mitotic system, we used a simple vortexing technique ([@bib8]) to compartmentalize reactions of cycling *Xenopus* egg extracts ([@bib22]) into microemulsion droplets, with radii ranging from 10 µm to 300 µm ([Figure 1B](#fig1){ref-type="fig"}, Materials and methods). The droplets were loaded into a Teflon-coated chamber and recorded using long-term time-lapse fluorescence microscopy. The fluorescence time courses of each droplet were analyzed to obtain information of period, amplitude, number of cycles, droplet size, etc.

To examine the functionality of the droplet mitotic system, we added de-membranated sperm chromatin, purified green fluorescent protein-nuclear localization signal (GFP-NLS), securin-mCherry mRNA and Hoechst 33342 dye to the cytoplasmic extracts. We demonstrated that the system is capable of reconstructing at least three mitotic processes in parallel that alternate between interphase and mitosis ([Figure 1---video 1](#fig1video1){ref-type="video"}). An example artificial cell that undergoes these mitotic processes is shown in [Figure 1C](#fig1){ref-type="fig"}. The autonomous alternation of distinct cell-cycle phases is driven by a self-sustained oscillator, the activity of which was indicated by the periodic degradation of an anaphase substrate of APC/C, securin-mCherry. In interphase, the presence of sperm chromosomal DNA, labeled by Hoechst, initiated the self-assembly of a nucleus, upon which GFP-NLS protein was imported through the nuclear pores. The spatial distributions of Hoechst and GFP-NLS thus coincided in an interphase nucleus ([Figure 1C](#fig1){ref-type="fig"} columns 1, 3, and 5). As the artificial cell entered mitosis, the chromosome condensed resulting in a tighter distribution of Hoechst, while the nuclear envelope broke down and GFP-NLS quickly dispersed into a uniform distribution in the whole droplet ([Figure 1C](#fig1){ref-type="fig"} columns 2 and 4). The time courses for these processes were analyzed in [Figure 1D](#fig1){ref-type="fig"}, indicating that the chromosome condensation and nuclear envelop breakdown (NEB) happened almost at the same time, while securin degradation lagged behind these two processes at each cycle. All together, these experiments showed that the droplet system successfully reconstituted a cell-free mitotic oscillator centered on Cdk1 and APC/C that can reliably drive the periodic progression of downstream events including chromosome morphology change and nuclear envelope breakdown and re-assembly, like what occurs in vivo.

The oscillator is effectively tunable in frequency with cyclin B1 mRNAs {#s2-2}
-----------------------------------------------------------------------

The ability to adjust frequency is an important feature shared by many oscillators ([@bib33]). Here, we demonstrated that the present system provides an effective experimental solution to the study of tunability of the clock. To avoid any interference from the complicated nuclear dynamics, we reconstituted a minimal mitotic oscillatory system which, in the absence of sperm chromatin, formed no nuclei. This simple, cytoplasmic-only oscillator produced highly robust, undamped, self-sustained oscillations up to 32 cycles over a lifetime of 4 days ([Figure 2A,B](#fig2){ref-type="fig"}, [Figure 2---video 1](#fig2video1){ref-type="video"}), significantly better than many existing synthetic oscillators.

![The minimal cell cycle oscillator is robust and tunable.\
(**A**) Fluorescence image of securin-mCherry, a reporter for the cell cycle oscillator, in micro-emulsion droplets (scale bar, 100 µm). One example droplet (inside the white dotted framed square) is selected for time course analysis in [Figure 2B](#fig2){ref-type="fig"}. (**B**) The time course of securin-mCherry fluorescence intensity of the selected droplet from [Figure 2A](#fig2){ref-type="fig"}, indicating 32 undamped oscillations over a course of 100 hr. (**C**) Simultaneous measurements of fluorescence intensities of securin-mCherry (upper panel) and cyclin B-YFP (lower panel), showing sustained oscillations for about 58 hr. The mRNA concentrations of securin-mCherry and cyclin B-YFP are 10 ng/µL and 1 ng/µL. The series of mCherry and YFP images correspond to selected peaks and troughs in the time courses of fluorescence intensities. The two channels have coincident peaks and troughs for all cycles, suggesting that they both are reliable reporters for the cell cycle oscillator. (**D, E**) The oscillator is tunable in frequency (**D**) and number of cycles (**E**) as a function of the concentration of cyclin B mRNAs. Cyclin B not only functions as a substrate of APC/C but also binds to Cdk1 for its activation, functioning as an 'input' of the clock. In [Figure 2D](#fig2){ref-type="fig"}, the cell cycle periods are shortened by increasing the mRNA concentrations. In [Figure 2E](#fig2){ref-type="fig"}, the number of total cell cycles is reduced in response to increasing cyclin B mRNA concentrations. Each data point represents a single droplet that was collected from one of the loading replicates (see Materials and methods 7). Red dashed line connects medians at different conditions. Error bar indicates median absolute deviation (MAD). (**F, G**) Droplets with smaller diameters have larger periods on average and a wider distribution of periods (**F**), and exhibit smaller number of oscillations on average (**G**). Colored areas represent moving 25 percentiles to 75 percentiles and is smoothed using the LOWESS smoothing method (see Materials and methods 7). The equivalent diameter is defined as the diameter of a sphere that has an equal volume to that of a droplet, estimated by a volume formula in literature ([@bib6]). Note that these size effects are smaller for droplets with higher cyclin B mRNA concentrations.\
10.7554/eLife.33549.005Figure 2---source data 1.Source data for generating [Figure 2D-E](#fig2){ref-type="fig"}.\
10.7554/eLife.33549.006Figure 2---source data 2.Source data for generating [Figure 2F-G](#fig2){ref-type="fig"}.](elife-33549-fig2){#fig2}

To modulate the speed of the oscillations, we supplied the system with various concentrations of purified mRNAs of full-length cyclin B1 fused to YFP (cyclin B1-YFP), which function both as a reporter of APC/C activity and as an activator of Cdk1. A droplet supplied with both cyclin B1-YFP and securin-mCherry mRNAs exhibited oscillations with highly correlated signals ([Figure 2C](#fig2){ref-type="fig"}, [Figure 2---video 2](#fig2video2){ref-type="video"}), suggesting that both are reliable reporters for the oscillator activity. With an increased concentration of cyclin B1-YFP mRNAs added to the system, we observed a decrease in the average period ([Figure 2D](#fig2){ref-type="fig"}, [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}), meaning that a higher cyclin B1 concentration tends to speed up the oscillations. However, the average number of cycles ([Figure 2E](#fig2){ref-type="fig"}, [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}) was also reduced with increased cyclin B1 concentrations, resulting in a negative correlation between the lifetime of oscillations and the amount of cyclin B1 mRNAs. The extracts will eventually arrest at a mitotic phase in the presence of high concentrations of cyclin B1.

The behavior of the single droplet oscillator is size-dependent {#s2-3}
---------------------------------------------------------------

Moreover, this system provides high flexibility in analyzing droplets with radii ranging from a few µm to 300 µm, enabling characterization of size-dependent behaviors of cell cycles. At the scale of a cell, the dynamics of biochemical reactions may become stochastic. Although stochastic phenomenon has been studied extensively in genetic expressions, studying a stochastic system that is out of steady-state can be challenging in living organism due to low throughput and complications from cell growth, divisions and other complex cellular environments. These limitations can be overcome by reconstitution of in vitro oscillators inside cell-scale droplets, which are in absence of cell growth and divisions. Parallel tracking of droplets also enables high-throughput data generation for statistical analysis. In vitro compartmentalization of molecules, especially rate-limiting molecules such as cyclin B1 mRNAs, into cell-sized droplets may have a major effect on the reaction kinetics of cell cycles. The smaller the size of a droplet, the smaller the copy number of molecules encapsulated inside the droplet and the larger the inherent stochasticity of biochemical reactions. Additionally, the partition errors of these molecule resulted from compartmentalization may further contribute to the variations of droplet behaviors in a size-dependent manner. [Figure 2F](#fig2){ref-type="fig"} ([Figure 2---source data 2](#fig2sdata2){ref-type="supplementary-material"}) showed that smaller droplets led to slower oscillations with a larger variance of the periods, consistent with the size effect reported on an in vitro transcriptional oscillator ([@bib36]). We also observed a reduced number of oscillations and a smaller variance of the cycle number in smaller droplets ([Figure 2G](#fig2){ref-type="fig"}, [Figure 2---source data 2](#fig2sdata2){ref-type="supplementary-material"}). Interestingly, these size effects become less dramatic for droplets with larger sizes or with higher concentrations of cyclin B1 mRNAs.

Energy depletion model recapitulates dynamics of the oscillator {#s2-4}
---------------------------------------------------------------

The results in [Figure 2D--G](#fig2){ref-type="fig"} indicated that the system is tunable by cyclin B1 mRNA concentration and droplet size in different manners. Although the period and number of cycles responded to varying droplet sizes in opposite directions, they followed the same trend when modulated by cyclin B1 mRNAs, resulting in a lifespan of the oscillatory system sensitive to cyclin B1 mRNA concentration. Moreover, we have observed that securin-mCherry and cyclin B1-YFP both exhibited oscillations of increased amplitude, baseline, and period over time ([Figure 2C](#fig2){ref-type="fig"}), of which the increasing period over time is evident by analysis in [Figure 3---figure supplement 1A and B](#fig3s1){ref-type="fig"}. These trends cannot be explained by existing cell cycle models ([@bib37]; [@bib34]).

Unlike intact embryos, cell-free extracts lack yolk as an energy source and lack sufficient mitochondria for energy regeneration. We postulated that energy is an important regulator for a droplet system with a limited amount of energy source consumed over time. To gain insights into our experimental observations and better understand the in vitro oscillator system, we built a model to examine how energy consumption plays a role in modulating the oscillation behaviors. The energy depletion model is based on a well-established cell-cycle model ([@bib37]; [@bib34]) modified by introducing ATP into all phosphorylation reactions ([Figure 3A](#fig3){ref-type="fig"}, Materials and methods 8 and 9).

![Simulation of cell cycle model with energy depletion.\
(**A**) Schematic view of the cyclin B-Cdk1 oscillation system. Note that ATP is taken into consideration. Activated molecules are marked in red, inactivated molecules in green and ATP or Pi in yellow. Black line indicates a reaction and blue dotted line a phosphorylation. (**B**) Relationship between ATP percentage and R value, showing that decreasing the ATP concentration leads to a higher R value. Error bars represent ranges from three simulations. Two inserts represent the dynamics of R value over time when the ATP percentage \[ATP\]/(\[ATP\]+\[ADP\]) is set as 0.2 (left) and 0.5 (right). The model is simulated using Gillespie algorithm. (**C**) Phase plots of the two-ODE model. Parameters for the cyclin B nullcline (Ncyc) ([@bib37]) and the Cdk1 nullclines with a variety of values of r (N1, r = 0.5; N2, r = 0.8; N3, r = 1.5; N4, r = 2.5) were chosen based on previous experimental work ([@bib26]; [@bib29]). Note that the r here is a parameter and is different from R in [Figure 3B](#fig3){ref-type="fig"}. Two sample traces of limit cycle oscillations are plotted for r = 0.8 (L1) and r = 1.5 (L2), showing that a larger r value leads to a higher amplitude and baseline. In addition, r = 0.5 (N1) generates a low stable steady-state of cyclin B (P1), while r = 2.5 (N4) a high stable steady-state of cyclin B (P4). These stable steady-states are indicated by the intersections of the nullclines (filled circles). The unstable steady states are labeled with open circles (P2 and P3). (**D**) Relationship between the oscillation baseline and amplitude values and ATP concentration (positively correlated with r). Error bars indicate the ranges of 3 replicates. Inserts show two example time courses of total cyclin B with different r values (L1, r = 0.8; L2, r = 1.5), colors of which match the ones in [Figure 3C](#fig3){ref-type="fig"}. Simulation is done using Gillespie algorithm. (**E**) Time series of total cyclin B molecules from the model without ATP (top panel, green line) and with ATP (bottom panel, yellow line).\
10.7554/eLife.33549.011Figure 3---source data 1.Simulated data for generating [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} using the energy depletion model.](elife-33549-fig3){#fig3}

In the cell cycle network, the activation of Cdk1 is co-regulated by a double positive feedback through a phosphatase Cdc25 and a double negative feedback through a kinase Wee1. The balance between Wee1 and Cdc25 activity was suggested to be crucial for the transition of cell cycle status during early embryo development ([@bib34]). In light of this, we defined the balance between Wee1 and Cdc25 by the ratio $R = \frac{k_{Wee1}\left\lbrack {Wee1} \right\rbrack}{k_{Cdc25}\left\lbrack {Cdc25} \right\rbrack}$. We noted that ATP-dependent phosphorylation of Cdc25 and Wee1 can decrease R by activating Cdc25 and inhibiting Wee1 simultaneously, resulting in a high dependence of R on the ATP concentration ([Figure 3B](#fig3){ref-type="fig"}).

Using this model, we further investigated the relationship between ATP and the oscillation behaviors. We introduce a parameter r into our system to systematically change the ratio R (see Materials and methods 8). In [Figure 3C](#fig3){ref-type="fig"}, the phase plot of the two-ODE model shows that at a low r (e.g. 0.5), the system stays at a stable steady-state with low cyclin B concentration and at a high r (e.g. 2.5), the oscillation is arrested at a stable steady-state with high cyclin B concentration. At an intermediate value, increasing r can produce oscillations of increased amplitude, baseline and period ([Figure 3C,D](#fig3){ref-type="fig"}). If we assume that the available ATP concentration decreases over time, we can readily recapitulate the experimentally observed increment of amplitude, baseline, and period of the cyclin B time course ([Figure 3E](#fig3){ref-type="fig"}). The energy depletion model can also predict the experimental observations in [Figure 2D and E](#fig2){ref-type="fig"} by showing that both period and number of cycles decrease with increasing cyclin B concentration ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}, [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}).

We noted that, besides phosphorylation, other processes, including protein synthesis and ubiquitination-mediated degradation, also consume ATPs and are sensitive to the energy level. However, the changes of synthesis and degradation rates yielded no obvious effects on the amplitude and baseline ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}).

We have developed here a novel artificial cell system that enables highly robust and tunable mitotic oscillations. The system is amenable to high throughput, quantitative manipulation and analysis of both cytoplasmic and nuclear processes. Given cell cycles share common topologies with many biological oscillators, the system may be valuable to investigate fundamental principles of oscillator theory.

Our energy depletion model suggested an interesting mechanism to modulate oscillations with a single control parameter r that depends on the energy-tunable balance of two positive feedback loops. Considering that the rapid, synchronous cleavages of an early embryo require a large amount of energy that remains unchanged for the first cleavage stages before rapidly dropping until the mid-blastula stage when cell cycles slow down ([@bib38]), this energy-dependent control may function as a 'checkpoint' to regulate cell cycles when r becomes large.

Materials and methods {#s3}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\        Designation                  Source or reference   Identifiers                                                    Additional information
  or resource                                                                                                                                      
  ------------------------------ ---------------------------- --------------------- -------------------------------------------------------------- --------------------------------
  Biological sample\             *Xenopus* eggs               Xenopus-I Inc.        RRID:[NXR_0.0080](https://scicrunch.org/resolver/NXR_0.0080)   
  (*Xenopus laevis*)                                                                                                                               

  recombinant DNA reagent        securin-mCherry              this paper                                                                           Progentiors: PCR;\
                                                                                                                                                   Gateway vector pMTB2

  recombinant DNA reagent        cyclin B1-YFP                this paper                                                                           

  recombinant DNA reagent        GST-GFP-NLS                  PMID: 23863935                                                                       Dr. James Ferrell\'s lab

  peptide, recombinant protein   GFP-NLS protein              this paper                                                                           BL21 (DE3)-T-1 competent cells

  commercial assay or kit        QIAprep spin miniprep kit    QIAGEN                Cat No.: 27104                                                 

  commercial assay or kit        mMESSAGE mMACHINE\           Ambion                Cat No.: AM1340                                                
                                 SP6 Transcription Kit                                                                                             

  Strain, strain background      BL21 (DE3)-T-1\              Sigma-Aldrich         Cat No.: B2935                                                 
                                 competent celss                                                                                                   

  chemical compound, drug        calcium ionophore            Sigma-Aldrich         Cat No.: A23187                                                

  chemical compound, drug        Hoechst 33342                Sigma-Aldrich         Cat No.: B2261                                                 

  chemical compound, drug        Trichloro (1H,1H,2H,2H-\     Sigma-Aldrich         Cat No.: 448931                                                
                                 perfluorooctyl) silane                                                                                            

  chemical compound, drug        PFPE-PEG surfactant          Ran Biotechnologies   008-FluoroSurfactant-\                                         
                                                                                    2wtH-50G                                                       

  other                          GE Healthcare Glutathione\   Sigma-Aldrich         Cat No.: GE17-0756-01                                          
                                 Sepharose 4B beads                                                                                                

  other                          PD-10 column                 Sigma-Aldrich         Cat No.: GE17-0851-01                                          

  other                          VitroCom miniature\          VitroCom              Cat No.: 5012                                                  
                                 hollow glass tubing                                                                                               
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Cycling *Xenopus laevis* extract preparation {#s3-1}
--------------------------------------------

Cycling *Xenopus* extracts were prepared as described ([@bib22]), except that eggs were activated with calcium ionophore A23187 (200 ng/µL) rather than electric shock. Freshly prepared extracts were kept on ice while applied with de-membranated sperm chromatin (to approximately 250 per µl of extract), GFP-NLS (10 µM) and recombinant mRNAs of securin-mCherry (10 ng/µL) and cyclin B1-YFP (ranging from 0 to 10 ng/µL). The extracts were mixed with surfactant oil 2% PFPE-PEG to generate droplets.

Fluorescence-labeled reporters {#s3-2}
------------------------------

GFP-NLS protein was expressed in BL21 (DE3)-T-1 competent cells (Sigma Aldrich, B2935) that were induced by 0.1 mM IPTG (Isopropyl β-D-1-thiogalactopyranoside, Sigma Aldrich, I6758) overnight. Cells were broken down to release protein through sonication. GE Healthcare Glutathione Sepharose 4B beads (Sigma Aldrich, GE17-0756-01) and PD-10 column (Sigma Aldrich, GE17-0851-01) were used to purify and elute GFP-NLS protein. 200 mg/ml Hoechst 33342 (Sigma Aldrich, B2261) was added to stain chromosomes. Securin-mCherry and cyclin B1-YFP plasmids were constructed using Gibson assembly method ([@bib4]). All mRNAs were transcribed in vitro and purified using mMESSAGE mMACHINE SP6 Transcription Kit (Ambion, AM1340).

Teflon-coated microchamber preparation {#s3-3}
--------------------------------------

VitroCom miniature hollow glass tubing with height of 100 µm (VitroCom, 5012) was cut into pieces with lengths of 3--5 mm. A heating block was heated up to 95°C in a Fisher Scientific Isotemp digital incubator and then it was placed into a Bel-art F42025-0000 polycarbonate vacuum desiccator with white polypropylene bottom. The cut glass tubes and a 1.5 ml Eppendorf tube containing 30 µl Trichloro (1 hr,1H,2H,2H-perfluorooctyl) silane (Sigma Aldrich, 448931) were placed in the heating block. Vacuum was applied to the desiccator and the tubes was left incubated overnight.

Generation of droplet-based artificial cells {#s3-4}
--------------------------------------------

To generate droplets, we used a Fisher Scientific vortex mixer to mix 20 µl cycling extract reaction mix, and 200 µl 2% PFPE-PEG surfactant (Ran Biotechnologies, 008-FluoroSurfactant-2wtH-50G) at speed level 10 for 3 s. By adjusting the vibration speed and ratio between aqueous and oil phase appropriately, we can obtain droplets with various sizes, ranging from 10 µm to 300 µm.

Time-lapse fluorescence microscopy {#s3-5}
----------------------------------

All imaging was conducted on an Olympus FV1200 confocal microscope under MATL mode (multiple area time lapse) and Olympus IX83 microscope equipped with a motorized x-y stage, at room temperature. Time-lapse images were recorded in bright-field and multiple fluorescence channels at a time interval of 6--9 min for at least 12 hr up to four days.

Image analysis and data processing {#s3-6}
----------------------------------

We used Imaris 8.1.2 (Bitplane Inc.) for image processing. Level-set method on bright-field images was used for droplet segmentation, and autoregressive motion algorithm was used for tracking. Tracks that had less than two oscillations were discarded. Results were then manually curated for accuracy. Means and standard deviations of fluorescence intensities as well as areas of each droplet were calculated for further analysis. The volume of a droplet was calculated using the formula proposed by a previous study ([@bib6]). To compensate for intensity drift over time, fluorescence intensity in droplets were normalized by average intensity of the background. For period calculation, Matlab (Mathworks Inc.) was used to detect peaks and troughs over the signal of mean intensity for cyclin B-YFP and securin-mCherry. All peaks were manually curated and edited to ensure reliability.

Statistical analysis {#s3-7}
--------------------

In [Figure 2D--E](#fig2){ref-type="fig"}, error bars indicate the median absolute deviations (MAD) of measurements pooled across multiple loading replicates. Each loading replicate refers to droplets encapsulated with extracts prepared from the same batch of *Xenopus* eggs that were loaded into a distinct individual Teflon-coated micro-chamber. For cyclin B mRNA concentrations of 0, 3, 5, 8, 10 ng/µL, respectively two, two, one, two and three loading replicates were performed, resulting in sample sizes of 373, 443, 227, 430 and 554 droplets that were analyzed. Extracts with cyclin B mRNA concentrations above 10 ng/µL did not exhibit sustained oscillations before arresting at a mitotic phase.

In [Figure 2F--G](#fig2){ref-type="fig"}, droplets generated with three cyclin B mRNA concentrations (0, 3, 5 ng/µL) were analyzed, with samples sizes of 246, 475, and 177 respectively. Experiments with cyclin B mRNA concentrations higher than 5 ng/µL showed similar behaviors as that of the 5 ng/µL cyclin B mRNA experiment and therefore are not included in the figures. Colored areas are defined by first and third quantiles after LOWESS (Locally Weighted Scatterplot Smoothing) with a window size of 20. The quartiles are calculated using running percentile with a binning size of 50. Volumes of droplets were first estimated using the compressed diameters ([@bib6]). The equivalent diameter was then calculated by the diameter of a sphere with the same volume as the estimated volume of a droplet.

In [Figure 3B and D](#fig3){ref-type="fig"}, we performed simulations at chosen ranges of ATP percentage ([Figure 3B](#fig3){ref-type="fig"}) and r ([Figure 3D](#fig3){ref-type="fig"}) to yield self-sustained oscillations. Error bars indicate the ranges of 3 independent simulations. The time courses in the figure inserts are randomly selected from the simulation replicates as examples.

In [Figure 3---figure supplement 1A and B](#fig3s1){ref-type="fig"}, measurements from experiments with 0 ng/µL cyclin B mRNA (from two loading replicates, 373 droplets, 5820 cycles) were pooled to analyze the change of period over time. In [Figure 3---figure supplements 1C](#fig3s1){ref-type="fig"}, 50 independent simulations were performed for each cyclin B mRNA concentration. Error bars indicate the standard deviations of the simulated data. In [Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}, the ranges of r and the degradation/synthesis rate were chosen to ensure all points in grids have self-sustained oscillations. All simulations in the supplementary figures were performed in a long enough time window to ensure stable statistics (period, amplitude) while the ATP concentration remained positive.

A two-ODE model of the embryonic cell cycle and stochastic simulations {#s3-8}
----------------------------------------------------------------------

Complicated models have been proposed to describe the embryonic cell cycle oscillation ([@bib25]; [@bib2]; [@bib27]; [@bib33]). However, simple two-ODE models with fewer parameters are more amenable to analysis, while still capturing the general property of the feedback loops. We described the net productions of cyclin B1 and active cyclinB-Cdk1 complex $\left\lbrack {Cdk1_{a}} \right\rbrack$ using the following two equations ([@bib37]; [@bib34]):$$\frac{d}{dt}\left\lbrack {CyclinB} \right\rbrack = k_{sy} - k_{deg}^{}\left\lbrack {CyclinB} \right\rbrack = k_{sy} - \left( {a_{deg} + \frac{b_{deg}\left\lbrack {Cdk1_{a}} \right\rbrack^{n_{deg}}}{\left\lbrack {Cdk1_{a}} \right\rbrack^{n_{deg}} + EC50_{deg}^{n_{deg}}}} \right)\left\lbrack {CyclinB} \right\rbrack$$$$\begin{matrix}
{\frac{d}{dt}\left\lbrack {Cdk1_{a}} \right\rbrack} & {\!\!\! = k_{sy} + k_{Cdc25}^{}\left\lbrack {Cdc25 - Pi} \right\rbrack\left( {\left\lbrack {CyclinB} \right\rbrack - \left\lbrack {Cdk1_{a}} \right\rbrack} \right) - k_{Wee1}^{}\left\lbrack {Wee1} \right\rbrack\left\lbrack {Cdk1_{a}} \right\rbrack} \\
 & {\quad - k_{deg}\left\lbrack {Cdk1_{a}} \right\rbrack} \\
 & {\quad = k_{sy}} \\
 & {\quad + \frac{1}{\sqrt{r}}\left( {a_{Cdc25} + \frac{b_{Cdc25}\left\lbrack {Cdk1_{a}} \right\rbrack^{n_{Cdc25}}}{\left\lbrack {Cdk1_{a}} \right\rbrack^{n_{Cdc25}} + EC50_{Cdc25}^{n_{Cdc25}}}} \right)\left( {\left\lbrack {CyclinB} \right\rbrack - \left\lbrack {Cdk1_{a}} \right\rbrack} \right)} \\
 & {\quad - \sqrt{r}\left( {a_{Wee1} + \frac{b_{Wee1}EC50_{Wee1}^{n_{Wee1}}}{\left\lbrack {Cdk1_{a}} \right\rbrack^{n_{Wee1}} + EC50_{Wee1}^{n_{Wee1}}}} \right)\left\lbrack {Cdk1_{a}} \right\rbrack} \\
 & {\quad - \left( {a_{deg} + \frac{b_{deg}\left\lbrack {Cdk1_{a}} \right\rbrack^{n_{deg}}}{\left\lbrack {Cdk1_{a}} \right\rbrack^{n_{deg}} + EC50_{deg}^{n_{deg}}}} \right)\left\lbrack {Cdk1_{a}} \right\rbrack} \\
\end{matrix}$$

The parameters for the model are listed below:

k~sy~1 nM/mina~wee1~0.08 nM/minb~wee1~0.4 nM/minn~wee1~3.5EC50~wee1~35 nMa~cdc25~0.16 nM/minb~cdc25~0.8 nM/minn~cdc25~11EC50~cdc25~30 nMa~deg~0.01 nM/minb~deg~0.04 nM/minn~deg~17EC50~deg~32 nM

Here, $\left\lbrack {CyclinB} \right\rbrack$ and $\left\lbrack {Cdk1_{a}} \right\rbrack$ refer to the concentrations of cyclin B1 and active cyclin B1-Cdk1 complex. $\left\lbrack Wee1 \right\rbrack$ is the concentration of active Wee1, while $\left\lbrack Cdc25 - Pi \right\rbrack$ is the concentration of active Cdc25. We assumed that Cyclin B1 is synthesized at a constant rate. Its degradation rate is dependent on Cdk1 activity in the form of a Hill function with an exponent of 17 ([@bib37]). Active cyclin B1-Cdk1 complex can also be eliminated through cyclin degradation. In addition, we considered the concentration of Cdk1 to be high compared to the peak concentration of cyclin B1 ([@bib9]; [@bib13]) and the affinity of these cyclins for Cdk1 to be high ([@bib14]). Thus, there is no unbound form of cyclin B1, and the newly synthesized cyclin B1 is converted to cyclin-Cdk1 complexes, which are rapidly phosphorylated by the Cdk-activating kinase CAK to produce active Cdk1. According to previous studies, these complexes can then be inactivated by Wee1 and re-activated by Cdc25, via the double-negative and positive feedback loops, with Hill exponent of $n_{Wee1}$ as 3.5 and $n_{Cdc25}$ as 11 ([@bib12]; [@bib32]).

We use a free parameter *r*, representing the ratio of the double negative and double positive feedback strengths, to permute the balance between the two feedbacks. This balance is suggested to be critical for oscillatory properties ([@bib34]). Note that this r is a parameter while R in the main text is a measurement that changes over a simulation.

In droplets that have small volumes and contain small numbers of molecules, the stochastic nature of the underlying biochemical reactions must be considered. We adapted a stochastic two-ODE model ([@bib37]), and converted our two-ODE model to the corresponding chemical master equations ([@bib11]) and carried out numerical simulations using the Gillespie algorithm ([@bib5]). The reaction rates and molecular stoichiometry are shown in [Table 1](#table1){ref-type="table"}.

10.7554/eLife.33549.012

###### Reaction rates and stoichiometry of the two-ODE model.

  Reaction                       Rate                                                                                                                                                                      Stoichiometry
  ------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------
  Active Cdk1 Synthesis          $\rho_{1} = k_{sy}$                                                                                                                                                       $< Cdk1_{a}\operatorname{>=<}Cdk1_{a} > + 1$
  Active Cdk1 to Inactive Cdk1   $\rho_{2} = \sqrt{r}\left( {a_{Wee1} + \frac{b_{Wee1}EC50_{Wee1}^{n_{Wee1}}}{< Cdk1_{a} >^{n_{Wee1}} + EC50_{Wee1}^{n_{Wee1}}}} \right) < Cdk1_{a} >$                     $< Cdk1_{a}\operatorname{>=<}Cdk1_{a} > - 1$$< Cdk1_{i}\operatorname{>=<}Cdk1_{i} > + 1$
  Inactive Cdk1 to Active Cdk1   $\rho_{3} = \frac{1}{\sqrt{r}}\left( {a_{Cdc25} + \frac{b_{Cdc25} < Cdk1_{a} >^{n_{Cdc25}}}{< Cdk1_{a} >^{n_{Cdc25}} + EC50_{Cdc25}^{n_{Cdc25}}}} \right) < Cdk1_{i} >$   $< Cdk1_{a}\operatorname{>=<}Cdk1_{a} > + 1$$< Cdk1_{i}\operatorname{>=<}Cdk1_{i} > - 1$
  Active Cdk1 Degradation        $\rho_{4} = \left( {a_{deg} + \frac{b_{deg} < Cdk1_{a} >^{n_{deg}}}{< Cdk1_{a} >^{n_{deg}} + EC50_{deg}^{n_{deg}}}} \right) < Cdk1_{a} >$                                 $< Cdk1_{a}\operatorname{>=<}Cdk1_{a} > - 1$
  Inactive Cdk1 Degradation      $\rho_{5} = \left( {a_{deg} + \frac{b_{deg} < Cdk1_{a} >^{n_{deg}}}{< Cdk1_{a} >^{n_{deg}} + EC50_{deg}^{n_{deg}}}} \right) < Cdk1_{i} >$                                 $< Cdk1_{i}\operatorname{>=<}Cdk1_{i} > - 1$

A stochastic model of the embryonic cell cycle including energy effect {#s3-9}
----------------------------------------------------------------------

To explore how energy consumption could affect the oscillations, we took ATP into account for phosphorylation and dephosphorylation of Wee1 ([@bib35]), such that:$$Wee1 + ATPWee1 - Pi + ADP$$

In our model, we assumed Wee1 is in equilibrium with the activity of Cdk1 due to fast reactions between Cdk1 and Wee1. Using the reaction coefficients for Wee1 phosphorylation as $k_{1Wee1}$ and that for Wee1-Pi dephosphorylation as $k_{2Wee1}$, along with the steady-state approximation, we have:$$k_{1Wee1}\left\lbrack {Wee1} \right\rbrack\left\lbrack {ATP} \right\rbrack = k_{2Wee1}\left\lbrack {Wee1 - Pi} \right\rbrack\left\lbrack {ADP} \right\rbrack\  = k_{2Wee1}\left( {\left\lbrack {Wee1_{tot}} \right\rbrack - \left\lbrack {Wee1} \right\rbrack} \right)\left( {1 - \left\lbrack {ATP} \right\rbrack} \right)$$

All above modifications for Wee1 reactions were also applied to Cdc25. After normalizing \[ATP\] and \[ADP\] by$\left\lbrack {ATP} \right\rbrack + \left\lbrack ADP \right\rbrack$, we have the updated reaction rates summarized in [Table 2](#table2){ref-type="table"}. Here the \[wee1\]~0~ and \[cdc25-Pi\]~0~ represent the steady-state concentration of active Wee1 and Cdc25 when ATP is not considered in reaction. The ratios of the steady-state to total concentrations of Wee1 and Cdc25 can be calculated as a function of active Cdk1 using the parameters from previous work ([@bib24]).

10.7554/eLife.33549.013

###### Reaction rates in the model considering ATP.

  Reaction                       Rate
  ------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Active Cdk1 Synthesis          $\rho_{1} = k_{sy}$
  Active Cdk1 to Inactive Cdk1   $\rho_{2} = 2\left\lbrack {ATP} \right\rbrack < Cdk1_{a} > \left( {a_{Wee1} + \frac{b_{Wee1}EC50_{Wee1}^{n_{Wee1}}}{< Cdk1_{a} >^{n_{Wee1}} + EC50_{Wee1}^{n_{Wee1}}}} \right)$$\left( \frac{1 - \left\lbrack {ATP} \right\rbrack}{\left\lbrack {ATP} \right\rbrack\left( {1 - \frac{2\left\lbrack {Wee1_{0}} \right\rbrack}{\left\lbrack {Wee1{}_{tot}} \right\rbrack}} \right) + \frac{\left\lbrack {Wee1_{0}} \right\rbrack}{\left\lbrack {Wee1_{tot}} \right\rbrack}} \right)$
  Inactive Cdk1 to Active Cdk1   $\rho_{3}\operatorname{=<}Cdk1_{i} > \left( {a_{Cdc25} + \frac{b_{Cdc25} < Cdk1_{a} >^{n_{Cdc25}}}{< Cdk1_{a} >^{n_{Cdc25}} + EC50_{Cdc25}^{n_{Cdc25}}}} \right)$$\left( \frac{\left\lbrack {ATP} \right\rbrack}{1 - \frac{\left\lbrack {Cdc{25 - Pi}_{0}} \right\rbrack}{\left\lbrack {Cdc25_{tot}} \right\rbrack} + \left( 2\frac{\left\lbrack {Cdc{25 - Pi}_{0}} \right\rbrack}{\left\lbrack {Cdc25_{tot}} \right\rbrack} - 1 \right)\left\lbrack ATP \right\rbrack} \right)$
  Active Cdk1 Degradation        $\rho_{4} = \left( {a_{deg} + \frac{b_{deg} < Cdk1_{a} >^{n_{deg}}}{< Cdk1_{a} >^{n_{deg}} + EC50_{deg}^{n_{deg}}}} \right)$$< Cdk1_{a} >$
  Inactive Cdk1 Degradation      $\rho_{5} = \left( {a_{deg} + \frac{b_{deg} < Cdk1_{a} >^{n_{deg}}}{< Cdk1_{a} >^{n_{deg}} + EC50_{deg}^{n_{deg}}}} \right)$$< Cdk1_{i} >$

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/100000001National Science Foundation MCB \#1612917 to Allen P Liu.

-   http://dx.doi.org/10.13039/100000002National Institutes of Health MIRA \#GM119688 to Qiong Yang.

-   http://dx.doi.org/10.13039/100000001National Science Foundation CAREER Grant \#1553031 to Qiong Yang.

-   http://dx.doi.org/10.13039/100000879Alfred P. Sloan Foundation Sloan Research Fellowship to Qiong Yang.

We thank Madeleine Lu for constructing securin-mCherry plasmid, Lap Man Lee and Kenneth Ho for discussions about droplet generation, Neha Bidthanapally and Zheng Yang for helping image processing, Jeremy B. Chang and James E. Ferrell Jr for providing GFP-NLS construct. QY is funded by the National Science Foundation (Early CAREER Grant \#1553031), the National Institutes of Health (MIRA \#GM119688), and a Sloan Research Fellowship. AP is funded by the National Science Foundation (MCB \#1612917).

Additional information {#s4}
======================

No competing interests declared.

Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing---original draft, Writing---review and editing.

Software, Formal analysis, Visualization, Writing---original draft, Writing---review and editing.

Formal analysis, Investigation.

Software, Formal analysis.

Software, Formal analysis.

Software, Help with data analysis.

Resources, Investigation.

Resources, Writing---review and editing.

Conceptualization, Software, Formal analysis, Supervision, Funding acquisition, Visualization, Methodology, Writing---original draft, Project administration, Writing---review and editing.

Additional files {#s5}
================

10.7554/eLife.33549.014

###### Source code to generate [Figure 1D](#fig1){ref-type="fig"} based on raw image file.
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###### Source code to generate [Figure 2D--E](#fig2){ref-type="fig"} and [Figure 2F--G](#fig2){ref-type="fig"} using [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"} and [Figure 2---source data 2](#fig2sdata2){ref-type="supplementary-material"} respectively.
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###### Source code to generate [Figure 3B--E](#fig3){ref-type="fig"}.
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###### Source code to generate [Figure 3---figure supplement 1A--B](#fig3s1){ref-type="fig"} using [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}.
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The following dataset was generated:
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"A robust and tunable mitotic oscillator in artificial cells\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by Naama Barkai as the Senior and Reviewing Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. Please address in full all comments of reviewer \#2.

*Reviewer \#1:*

Guan et al. present a highly interesting manuscript showing that a few simple components in the cell cycle machinery can generate oscillations in vitro in droplets. They showed robust oscillatory behaviors and how the oscillations can be tuned by the size of the droplets as well as by concentrations of cyclin mRNAs. The theoretical work showed that the ratio of Cdc25 and Wee1 affect the oscillation timing. They further showed that the energy depletion model is consistent with the experimental results. The experiments are elegantly carried out and the results are beautiful. I would recommend for publication in *eLife*.

*Reviewer \#2:*

This paper reports on the development of a droplet assay in which cytoplasmic extracts can be compartmentalized to sizes in the micrometer range. This allows the authors to generate artificial mitotic oscillations using an in vitro setup that combines the ease of manipulation and control of bulk cell-free extracts with the realism of cell-size compartmentalization (in terms of heterogeneity and sustained dynamics). The observed sustained oscillations (Figure 2B) are certainly noteworthy, and the assay does allow for a valuable study of how the period of the oscillator depends on \"cell\" size and on the availability of one of the clock components (cyclin B1). The setup also enables the authors to conjecture that the amplitude and period of the oscillator depend on the energy available to the cell in terms of ATP, a fact that is studied computationally but not experimentally. I would like to raise the following points about this work:

1\) The oscillations shown in Figure 1C, D are really interesting, given that they exist even in the presence of nuclear self-assembly and disassembly. I was wondering if the extra compartmentalization provided by the nucleus would have an impact on the oscillations reported in Figure 2. Would the authors be able to obtain self-sustained oscillations for long periods in the presence of a nucleus? This would bring the results closer to real-life situations.

2\) Figures 2F and G show that the period and lifetime of the oscillations are rather independent of \"cell\" sizes for large sizes. I think it\'d be interesting to relate these results to real cells, by taking into account the range of sizes that real cells exhibit (keeping in mind again that these \"cells\" don\'t have a nucleus, see my preceding comment).

3\) The way the modeling results are being presented makes it difficult to understand what is being done. The title of the caption of Figure 3 refers to a \"stochastic model\", but as far as I understand the results of Figure 3C have been obtained with an ODE model, in the absence of fluctuations, and probably those of Figure 3E too. Figure 3B, on the other hand, has been presumably obtained with a stochastic model (since this seems to be the way in which ATP can be included in the model described in the Materials and methods section), before the stochastic description is mentioned in the text. On the other hand, the time traces in the insets look very clean, seemingly obtained from an ODE model. A similar comment can be made regarding Figure 3D. Can the authors clarify what is being shown in Figure 3?

4\) Figure 3C is really hard to follow. I would ask the authors to plot the steady states (at least the stable ones, and preferably all) as symbols, and to represent the trajectories in colors different from those of the corresponding nullclines.

Finally, I have two suggestions that are not essential to support the major conclusions of the paper, but would (in my opinion) enrich it:

5\) I\'m wondering if the range of droplet sizes that has been studied has been selected on purpose by the authors, or if there is some limitation resulting from the experimental process. I\'m asking because it would be interesting, in my opinion, to see what happens with the oscillations as the size of the droplets increases. For what droplet size does the oscillation dampening typical of bulk extracts is recovered in these experiments?

6\) It would also be desirable to validate the modeling results of Figure 3 experimentally by controlling experimentally the amount of available ATP and measure the corresponding effect on the oscillation characteristics.

10.7554/eLife.33549.030

Author response

> Reviewer \#1:
>
> Guan et al. present a highly interesting manuscript showing that a few simple components in the cell cycle machinery can generate oscillations in vitro in droplets. They showed robust oscillatory behaviors and how the oscillations can be tuned by the size of the droplets as well as by concentrations of cyclin mRNAs. The theoretical work showed that the ratio of Cdc25 and Wee1 affect the oscillation timing. They further showed that the energy depletion model is consistent with the experimental results. The experiments are elegantly carried out and the results are beautiful. I would recommend for publication in eLife.

We thank reviewer 1 for this positive assessment of our work. We are excited that you enjoyed our work.

> Reviewer \#2:
>
> This paper reports on the development of a droplet assay in which cytoplasmic extracts can be compartmentalized to sizes in the micrometer range. This allows the authors to generate artificial mitotic oscillations using an in vitro setup that combines the ease of manipulation and control of bulk cell-free extracts with the realism of cell-size compartmentalization (in terms of heterogeneity and sustained dynamics). The observed sustained oscillations (Figure 2B) are certainly noteworthy, and the assay does allow for a valuable study of how the period of the oscillator depends on \"cell\" size and on the availability of one of the clock components (cyclin B1). The setup also enables the authors to conjecture that the amplitude and period of the oscillator depend on the energy available to the cell in terms of ATP, a fact that is studied computationally but not experimentally. I would like to raise the following points about this work:
>
> 1\) The oscillations shown in Figure 1C, D are really interesting, given that they exist even in the presence of nuclear self-assembly and disassembly. I was wondering if the extra compartmentalization provided by the nucleus would have an impact on the oscillations reported in Figure 2. Would the authors be able to obtain self-sustained oscillations for long periods in the presence of a nucleus? This would bring the results closer to real-life situations.

To investigate the effect of the nucleus, we compared the oscillation behaviors of two groups of droplets prepared from the same batch of extracts in the same day, one group with demembranated *Xenopus* sperm chromatin added and one without. The presence of nuclear self-assembly and disassembly seems to reduce the overall lifespan of oscillations (Figure 1C) and lengthen the periods (Figure 1B). The reduced lifespan of oscillations could be explained by faster energy depletion in droplets with nuclei, as nuclear pore transportation, chromosome condensation and the nuclear envelope formation/breakdown would consume energy. Moreover, compared to the cytoplasmic-only droplets, cyclin-CDKs in droplets with nuclei would need to phosphorylate more substrates required for regulating the downstream nuclear events and the transportation of molecules into/out of nucleus would take time, which could explain why adding sperm DNA may elongate the cycle period. Together, the reduced lifespan and the extended oscillation periods lead to a smaller number of oscillations (Figure 1A).

We also observed that the effect of adding sperm DNAs is more obvious in large droplets (Figure 1D, E), likely due to the fact that some small droplets may have no sperm DNA encapsulated.

![A-C Statistics of droplets with sperm DNA (N=320) and without sperm DNA (N=373).\
All droplets were prepared in the same day from the same batch of frog eggs. The figures show that adding sperm DNA may cause significant difference in number of oscillations (**A**), period (**B**) and oscillation sustaining time (**C**). D-E. Droplet-size dependence of period (**D**) and number of oscillations (**E**) with nucleus effect, showing that adding sperm DNAs has a more significant impact on larger droplets.](elife-33549-resp-fig1){#respfig1}

> 2\) Figures 2F and G show that the period and lifetime of the oscillations are rather independent of \"cell\" sizes for large sizes. I think it\'d be interesting to relate these results to real cells, by taking into account the range of sizes that real cells exhibit (keeping in mind again that these \"cells\" don\'t have a nucleus, see my preceding comment).

We thank reviewer 2 for bringing up this interesting question. The real cell size spans a large range. An egg cell like *Xenopus* or zebrafish is around 1mm in diameter. Upon fertilization, the embryo undergoes rapid and reductive divisions in the absence of growth, cleaving it into smaller and smaller cells down to 10 μm in diameter. A cultured mammalian cell has a size of around 20 µm.

In our system, droplet size varies from around 200 µm (large droplets) in diameter to around 10 µm (small droplets), covering the range of sizes from an embryonic cell after the 7^th^ cleavage to a somatic-sized blastomere. A direct comparison of our droplets to embryonic cells might not be feasible since these droplets do not have a nucleus. In addition, most of the embryo volume is taken by yolk and the relevant cytosol volume of the embryo might only take up a small portion. However, we could explore the mechanism of the size effect on the cell cycle period within our droplet system that may be extendable to real cells.

In our ongoing project, we are trying to relate the size dependency of period to that observed in actual embryo cleavages. Published results on early embryo cleavages in both zebrafish (Citation: Figure 4A and 4B in Olivier et al., Science 2010) and *Xenopus* (Citation: Figure 2B and 2F in Anderson et al., Cell Report 2017) support that the cell cycle accelerates at the beginning of the cleavages and slows down as cells get smaller (Anderson et al., 2017; Olivier et al., 2010). The same result could be observed in our system if we assume a large droplet of 200 µm in diameter undergoes multiple cycles of cleavages in a thought experiment ([Author response image 2](#respfig2){ref-type="fig"}). Here we sorted the droplets in Figure 2F of the main text based on their size to simulate the first ten cleavages. The periods of all droplets within certain diameters are grouped. The result suggests that when droplets are getting smaller, their periods decrease a little at the beginning and then increase, comparable to the trend observed in early embryonic divisions.

![A thought experiment of a droplet of 200 µm in diameter undergoing ten divisions.\
The cell cycle period is calculated for each division, with each corresponding diameter labeled on the figure. The error bar is showing 25^th^ and 75^th^ percentile as in Figure 2F in the main text.](elife-33549-resp-fig2){#respfig2}

> 3\) The way the modeling results are being presented makes it difficult to understand what is being done. The title of the caption of Figure 3 refers to a \"stochastic model\", but as far as I understand the results of Figure 3C have been obtained with an ODE model, in the absence of fluctuations, and probably those of Figure 3E too. Figure 3B, on the other hand, has been presumably obtained with a stochastic model (since this seems to be the way in which ATP can be included in the model described in the Materials and methods section), before the stochastic description is mentioned in the text. On the other hand, the time traces in the insets look very clean, seemingly obtained from an ODE model. A similar comment can be made regarding Figure 3D. Can the authors clarify what is being shown in Figure 3?

We thank reviewer 2 for the careful thought and for raising these points. To clarify, Figure 3C and Figure 3E top panel from the main text are not stochastic and are obtained from an ODE model; others (Figures 3B, 3D, and 3E bottom panel of the main text) are from a stochastic model. The simulation code has been included in the source manuscript files. To avoid the confusion, we have removed "stochastic model" from the title of Figure 3 in the main text. We have also modified Figure 3C and Figure 3D for clearer presentation of the modeling results.

The stochastically simulated trace looks smooth because we assumed a system of 1 pL in volume (comparable to our typical droplet volume) and the total number of molecules is high enough to produce a deterministic ODE-like response. As an example, we replot Figure 3E bottom panel from the main text to show the effects of the volume (or the total number of molecules). As shown in [Author response image 3](#respfig3){ref-type="fig"}, when droplet size is above 0.1 pL, no obvious kinks can be observed. Note that we have used the standard Gillespie algorithm for stochastic simulation, which considers the reaction stochasticity alone. But in real cases, the diffusive stochasticity might play a role, which is not considered in current simulation.

![Reproduction of Figure 3E bottom panel from the main text with different reaction volumes.](elife-33549-resp-fig3){#respfig3}

> 4\) Figure 3C is really hard to follow. I would ask the authors to plot the steady states (at least the stable ones, and preferably all) as symbols, and to represent the trajectories in colors different from those of the corresponding nullclines.

Figure 3C and the caption have been changed as reviewer 2 suggested.

> Finally, I have two suggestions that are not essential to support the major conclusions of the paper, but would (in my opinion) enrich it:
>
> 5\) I\'m wondering if the range of droplet sizes that has been studied has been selected on purpose by the authors, or if there is some limitation resulting from the experimental process. I\'m asking because it would be interesting, in my opinion, to see what happens with the oscillations as the size of the droplets increases. For what droplet size does the oscillation dampening typical of bulk extracts is recovered in these experiments?

We thank reviewer 2 for this interesting question. We did not select the droplet sizes on purpose, but we performed all experiments at a fixed vortexing speed and duration. At this vortexing condition, we could obtain droplets of sizes ranging from about 10 µm to 300 µm ([Author response image 4](#respfig4){ref-type="fig"}). Droplet sizes beyond 200 µm are rare. In an unusually large droplet (beyond 500 µm) such as the one example shown in [Author response image 5](#respfig5){ref-type="fig"}, we could start to observe wave propagation across the droplet. Such spatial asynchrony (i.e. oscillations at different locations are out of phase) could potentially contribute to damped oscillations typical of a bulk ensemble measurement, even though oscillation at a specific location is sustained and has amplitude/period/lifetime comparable to a relatively smaller droplet. We could also take a population average of traces of all droplets in one experiment, to mimic the behaviors of bulk extracts.

![Size distribution for 1997 droplets obtained using a specific vortexing speed and duration.](elife-33549-resp-fig4){#respfig4}

![Mitotic trigger waves in a large droplet.](elife-33549-resp-fig5){#respfig5}

> 6\) It would also be desirable to validate the modeling results of Figure 3 experimentally by controlling experimentally the amount of available ATP and measure the corresponding effect on the oscillation characteristics.

To explore the energy dependent behaviors experimentally, we tested droplets supplied with a variety of concentrations of energy mix. We define the standard concentration of energy mix, which we use in the article, as 1x. For all energy mix concentrations that we tested (ranging from 0 to 10x), we did not observe any oscillations in droplets with energy mix beyond 2x. In the following, we analyzed the oscillation behaviors in droplets prepared from the same batch of extracts except that they were supplied with different concentrations of energy mix (0x, 0.5x, 1x, 1.5x, with each condition performed in duplicate). As shown in [Author response image 6](#respfig6){ref-type="fig"}, there is a clear trend of decreasing baseline, amplitude, and period as the amount of energy mix is increasing, which is consistent with our modeling results. The dependence of period and amplitude on the energy level is quantitatively analyzed in [Author response image 7](#respfig7){ref-type="fig"}.

![Time traces of individual droplets with different concentrations of energy mix.\
Each condition has two duplicate experiments and only one is shown. It is evident that the amplitude, baseline, and period decrease as the level of energy mix increases.](elife-33549-resp-fig6){#respfig6}

![Amplitude (left panel) and period (right panel) decrease as energy mix concentration increases.](elife-33549-resp-fig7){#respfig7}

[^1]: These authors contributed equally to this work.
